Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer.

@article{Zhang2012LossOH,
  title={Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer.},
  author={Lewei Zhang and Catherine F Poh and Michele Williams and Denise Marie Laronde and Kenneth W. Berean and Pamela J. Gardner and Huijun Jiang and Lang Ping Wu and Julie J Lee and Miriam Pearl Rosin},
  journal={Cancer prevention research},
  year={2012},
  volume={5 9},
  pages={
          1081-9
        }
}
A major barrier to oral cancer prevention has been the lack of validated risk predictors for oral premalignant lesions (OPL). In 2000, we proposed a loss of heterozygosity (LOH) risk model in a retrospective study. This paper validated the previously reported LOH profiles as risk predictors and developed refined models via the largest longitudinal study to date of low-grade OPLs from a population-based patient group. Analysis involved a prospective cohort of 296 patients with primary mild… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 49 CITATIONS

Histological clonal change - A feature for dysplasia diagnosis

VIEW 13 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
HIGHLY INFLUENCED

Individualized five-year risk assessment for oral premalignant lesion progression to cancer.

  • Oral surgery, oral medicine, oral pathology and oral radiology
  • 2017
VIEW 13 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Predicting progression of oral dysplasia--letter.

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 29 REFERENCES

Cancer and ageing: convergent and divergent mechanisms

  • Nature Reviews Molecular Cell Biology
  • 2007
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2000
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

The cetuximab for treatment of high-risk premalignant upper aerodigestive lesions trial

Lewei Zhang, Catherine F. Poh, Michele Williams
  • Cancer Prev Res;
  • 2011
VIEW 1 EXCERPT

Cancer incidence and mortality Worldwide

J SHFerlay, D Forman, CD Mathers, D. Parkin
  • In: GLOBOCAN: IARC CancerBase;
  • 2008
VIEW 1 EXCERPT

Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.

  • Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • 2006

Similar Papers

Loading similar papers…